Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115199) titled 'A study on the safety and efficacy of tirofiban in elderly patients with acute cerebral infarction' on Dec. 23, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Hengzhou People's Hospital
Condition:
(Within 24 hours of onset) Acute cerebral infarction, acute ischemic stroke.
Intervention:
Experimental group:Intravenous infusion of tirofiban for the first 48 hours
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-09-12
Target Sample Size: Experimental group:180;control group:180;
Countries of Recruitment:
China
To know more, visit https://www.chic...